Groundbreaking research about long term contin... - CLL Support
Groundbreaking research about long term continuous venetoclax therapy for chronic lymphocytic leukaemia
You need to be a member of this community to see this post.
Read more about...
20 Replies
You need to be a member of this community to see hidden responses.
Not what you're looking for?
You may also like...
Long-Term Ibrutinib Therapy Reverses CD8+ T Cell Exhaustion in B Cell CLL
Chronic Lymphocytic Leukaemia (CLL) is associated with immune suppression and susceptibility to...
Chronic Lymphocytic Leukemia Therapy Guided by Measurable Residual Disease
From the New England Journal of Medicine 10th December 2023
"The CLL treatment landscape has...
Growth dynamics in naturally progressing chronic lymphocytic leukaemia
Abstract from Nature, 29/5/19 - Unfortunately the whole article is behind a paywall.
"We used...
Encouraging results from venetoclax retreatment of patients with chronic lymphocytic leukemia after a previous venetoclax-based regimen
We've heard that re-treatment with venetoclax is possible. Per the attached image, here's some...
ASH 2019: A Clinical Trial of Cannabis As Targeted Therapy for Indolent Leukemic Lymphoma
"Conclusion:
This study demonstrates that it is safe to administrate a single dose of Sativex to...
Related Posts
- Ibrutinib Plus Venetoclax in Relapsed/Refractory Chronic Lymphocytic Leukemia: Update on The CLARITY Study
- Relative risk for secondary bone marrow cancer within 5 years after initial CLL chemoimmunotherapy treatment (typically BR or FCR)
- Breakthrough in laboratory production of red blood cells towards saving lives of those with Chronic Lymphocytic Leukaemia in the future
- Leukaemia Care Updated Patient Information - Richter's Syndrome in Chronic Lymphocytic Leukaemia
- Acalabrutinib Plus Obinutuzumab Prolongs Progression Free Survival Compared to Other Targeted Agents in Chronic Lymphocytic Leukaemia (CLL)
